Figure 4:

Blind men and the elephant of CKD prevention and treatment. Over the years, different trials testing different SGLT2 inhibitors in different populations with different primary or secondary outcomes and post hoc analyses have provided insight into the potential of CKD inhibitors to prevent and treat CKD. The results of these trials should be integrated for a better appreciation of the role of SGLT2 inhibition in kidney protection, in a similar manner that the different touching experiences of the blind men in the Indian parable of the blind men and an elephant should be integrated to learn about the elephant. Adapted from reference [37] (artist: G. Renee Guzlas). All rights reserved ©. Reproduced by permission of J. Himmelfarb, P. Stenvinkel, T.A. Ikizler and R. M. Hakim.